Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Raw Materials (2016 - 2024)

Utah Medical Products (UTMD) has 14 years of Raw Materials data on record, last reported at $5.5 million in Q4 2024.

  • For Q4 2024, Raw Materials fell 14.22% year-over-year to $5.5 million; the TTM value through Dec 2024 reached $5.5 million, down 14.22%, while the annual FY2024 figure was $5.5 million, 14.22% down from the prior year.
  • Raw Materials reached $5.5 million in Q4 2024 per UTMD's latest filing, down from $6.3 million in the prior quarter.
  • Across five years, Raw Materials topped out at $6.5 million in Q1 2023 and bottomed at $3.4 million in Q3 2021.
  • Average Raw Materials over 5 years is $4.9 million, with a median of $4.9 million recorded in 2022.
  • Peak YoY movement for Raw Materials: decreased 16.71% in 2020, then skyrocketed 61.25% in 2023.
  • A 5-year view of Raw Materials shows it stood at $3.5 million in 2020, then grew by 7.06% to $3.7 million in 2021, then skyrocketed by 53.49% to $5.7 million in 2022, then increased by 11.69% to $6.4 million in 2023, then decreased by 14.22% to $5.5 million in 2024.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $5.5 million in Q4 2024, $6.3 million in Q3 2024, and $6.3 million in Q2 2024.